PAR PHARMACEUTICAL COMPANIES, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2010. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2010-07-02: Reporting owner Tropiano Michael A; Form 3; Security Common Stock, Option to Buy; Transaction Holding.
- 2010-07-02: Reporting owner Tropiano Michael A; Form 3; Security Common Stock, Option to Buy; Transaction Holding.
- 2010-07-02: Reporting owner Tropiano Michael A; Form 3; Security Common Stock, Option to Buy; Transaction Holding.
- 2010-07-02: Reporting owner Tropiano Michael A; Form 3; Security Common Stock, Option to Buy; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2010-07-02 holding as of filing | Tropiano Michael A Officer (Executive Vice Pres. & CFO) | 3 | Common Stock, Option to Buy Derivative · Direct | Holding | $24.49 exercise price | 2010-07-02 | ||
| 2010-07-02 holding as of filing | Tropiano Michael A Officer (Executive Vice Pres. & CFO) | 3 | Common Stock, Option to Buy Derivative · Direct | Holding | $33.62 exercise price | 2010-07-02 | ||
| 2010-07-02 holding as of filing | Tropiano Michael A Officer (Executive Vice Pres. & CFO) | 3 | Common Stock, Option to Buy Derivative · Direct | Holding | $24.27 exercise price | 2010-07-02 | ||
| 2010-07-02 holding as of filing | Tropiano Michael A Officer (Executive Vice Pres. & CFO) | 3 | Common Stock, Option to Buy Derivative · Direct | Holding | $13.06 exercise price | 2010-07-02 | ||
| 2010-07-02 holding as of filing | Tropiano Michael A Officer (Executive Vice Pres. & CFO) | 3 | Common Stock, Option to Buy Derivative · Direct | Holding | $27.71 exercise price | 2010-07-02 | ||
| 2010-03-03 | KENYON LAWRENCE A Officer (EVP, Chief Financial Officer) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,439 64,319 owned after | $13.06 exercise price | 2010-03-03 | |
| 2010-03-02 | Campanelli Paul Officer (EVP; President - Generics) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,885 74,656 owned after | $13.06 exercise price | 2010-03-03 | |
| 2010-03-01 | HAUGHEY THOMAS Officer (EVP, CAO, Gen Counsel) | 4 | Common Stock, Option to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,799 80,399 owned after | $13.06 exercise price | 2010-03-03 | |
| 2010-01-04 | KENYON LAWRENCE A Officer (EVP, Chief Financial Officer) | 4/A | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,653 21,653 owned after | $27.71 exercise price | 2010-01-08 | |
| 2010-01-04 | MacPhee John A Officer (EVP, Pres-Strativa) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,457 23,457 owned after | $27.71 exercise price | 2010-01-06 | |
| 2010-01-04 | Campanelli Paul Officer (EVP, Pres-Generics) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,457 23,457 owned after | $27.71 exercise price | 2010-01-06 | |
| 2010-01-04 | KENYON LAWRENCE A Officer (EVP, Chief Financial Officer) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,653 21,563 owned after | $27.71 exercise price | 2010-01-06 | |
| 2010-01-04 | HAUGHEY THOMAS Officer (EVP, Chief Admin Off, Gen Coun) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,262 25,262 owned after | $27.71 exercise price | 2010-01-06 | |
| 2010-01-04 | LEPORE PATRICK G Director, Officer (Chairman, President & CEO) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +54,132 54,132 owned after | $27.71 exercise price | 2010-01-06 |